灿盛制药（淄博）有限公司由山东新华制药股份有限公司和荷兰灿盛制药国际公司于1995年共同投资组建，主要生产经营头孢菌素类产品。CentrientPharmaceuticals(Zibo)Co.,Ltd.(previouslycalledSinochemPharmaceuticals(Zibo)Co.,Ltd)isajointventurebetweenShandongXinhuaPharmaceuticalsandCentrientPharmaceuticalInternationalB.V.oftheNetherlands,mainlyengagingproducingcephalosporins.
荷兰灿盛制药国际公司是β-内酰胺类抗感染药物的全球领先者，同时经营新一代抗真菌类药物和降血脂类药物，拥有全球领先的绿色酶法技术，在全球多个大洲和国家内进行生产和销售。CentrientPharmaceuticalsistheleadingmanufacturerinBeta-lactamanti-biotics,andaproviderinnextgenerationstatinsandanti-fugals.Itsworld-leadingenzymatictechnologyenableasustainableproductionandsalesacrossseveralcontinentsandmanycountries.山东新华制药股份有限公司是H股、A股上市公司，全国重要的解热镇痛药生产和出口基地、拥有化学原料药、医药制剂、医药中间体、医药商业物流四大支柱产业。ShandongXinhuaPharmaceuticalsislistedcompanyinHKandShanghaistockmarket,oneoftheimportantproductionandexportbaseforanalgesic&antipyreticdrugs,withits4foundingpillarsinchemicalbulks,finisheddosage,pharmaceuticalintermediateandpharmaceuticalcommerciallogistics.这一中外制药集团之间的强强合作，极大地促进了灿盛淄博的发展。目前公司有两个生产基地，总生产能力超千吨；销售收入由成立初期的8500多万元增至目前的约4亿元人民币，为国内最大的头孢菌素类原料药供应商之一。ThesupportfrombothshareholdersstronglyfacilitateCentrientZiboinitsdevelopment.Tillnow,CentrientZibohastwomanufacturingsites,withoutputexceeding1000tonsperyear;itsrevenueincreasedfrom85millionRMBtoaround400millionRMB,andbecomesoneofthelargestproviderofcephlosporinsinChina.